Search

Filters

Clear Filters
8:05 AM - 8:10 AM ET

1205 - Guideline Grounded Agentic Retrieval System Shows Near Expert Performance among Fourteen Radiation Oncology Disease Sites
Speaker: Patel, Kishan, MD - McGaw Medical Center of Northwestern University, Chicago, IL
8:10 AM - 8:15 AM ET

1206 - Clinical Implementation of an AI-Assisted Workflow for Systematic Clinical Trial Eligibility Prescreening
Speaker: Rosenthal, Jacob, MS - Memorial Sloan Kettering Cancer Center, New York, NY
8:15 AM - 8:20 AM ET

1207 - Pilot/Feasibility Study of Early Lung Cancer Detection from Standard CT Simulation for Breast Cancer Radiotherapy
Speaker: Gregucci, Fabiana - Weill Cornell Medical College, New York, NY
8:20 AM - 8:25 AM ET

1208 - Patient-Centered Visualization in Telehealth: A Digital Innovation to Improve Understanding, Satisfaction and Quality of Care
Speaker: Polce, Simran, MD - Moffitt Cancer Center, Tampa, FL
8:25 AM - 8:30 AM ET

1209 - Reducing Documentation Burden in Radiation Oncology: Automated Treatment Summaries Using a Two-Stage Large Language Model System
Speaker: Lin, Keldon, MD, MS - Mayo Clinic College of Medicine and Science Rochester, Rochester, MN
3:00 PM - 3:10 PM ET

121 - Pirfenidone for Cancer Patients with Grade 2 and Grade 3 Radiation-Induced Lung Injury: Long-Term Efficacy and Exploratory Analysis from a Multicenter, Randomized Phase ll Clinical Trial
Speaker: Chen, Biqi, MD - Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
8:30 AM - 8:35 AM ET

1210 - Modernizing the MD Anderson Stiefel Oropharynx Cancer Cohort Database through Development and Validation of Automated Data Extraction Algorithms
Speaker: Rinsurongkawong, Waree, PhD - MD Anderson Cancer Center, Houston, TX
8:05 AM - 8:10 AM ET

1211 - Contemporary Outcomes with Endoluminal High-Dose-Rate Brachytherapy for Esophageal Cancer
Speaker: Wu, Abraham, MD - Memorial Sloan Kettering Cancer Center, New York, New York
8:10 AM - 8:15 AM ET

1212 - Consolidation Chemotherapy after Definitive Concurrent Chemoradiotherapy in Patients with Locally Advanced, Inoperable Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Non-inferiority, Phase 3 Trial
Speaker: Fan, ChengCheng, MD - Henan Cancer Hospital, Zhengzhou, HeNan
8:15 AM - 8:20 AM ET

1213 - Long-Term Survival and Biomarker-Based Exploratory Analysis of Nimotuzumab Combined with SIB-IMRT in Locally Advanced Esophageal Cancer: Insights from a Phase II Clinical Trial
Speaker: Wang, Lan, MD - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province
8:20 AM - 8:25 AM ET

1214 - Proton vs. Photon EBRT for Hepatocellular Carcinoma: A Multi-Institutional Individual Patient Data Analysis Using Propensity Score Weighting
Speaker: Yanagihara, Ted, MD, PhD - University of North Carolina, Chapel Hill, NC
8:25 AM - 8:30 AM ET

1215 - Long-Term Outcomes of Image-Guided Proton Therapy for Treatment-Naïve Solitary Hepatocellular Carcinoma Amenable to Surgical Resection or Radiofrequency Ablation: A Pooled Analysis of a Phase II Trial and Prospective Cohort
Speaker: Iwata, Hiromitsu, MD, PhD - Nagoya Proton Therapy Center, Nagoya City University West Medical Center, Nagoya, Aichi